Accéder au contenu
Merck

GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways.

International journal of molecular sciences (2015-09-18)
Kun Liu, Qing Zhang, Haitao Lan, Liping Wang, Pengfei Mou, Wei Shao, Dan Liu, Wensheng Yang, Zhen Lin, Qingyuan Lin, Tianhai Ji
RÉSUMÉ

The general control of nucleotide synthesis 5 (GCN5), which is one kind of lysine acetyltransferases, regulates a number of cellular processes, such as cell proliferation, differentiation, cell cycle and DNA damage repair. However, its biological role in human glioma development remains elusive. In the present study, we firstly reported that GCN5 was frequently overexpressed in human glioma tissues and GCN5 was positively correlated with proliferation of cell nuclear antigen PCNA and matrix metallopeptidase MMP9. Meanwhile, down-regulation of GCN5 by siRNA interfering inhibited glioma cell proliferation and invasion. In addition, GCN5 knockdown reduced expression of p-STAT3, p-AKT, PCNA and MMP9 and increased the expression of p21 in glioma cells. In conclusion, GCN5 exhibited critical roles in glioma development by regulating cell proliferation and invasion, which suggested that GCN5 might be a potential molecular target for glioma treatment.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human KAT2A
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Kat2a